S&P 500 7,420.10 â–ŧ 91.25 (-1.21%) DOW 51,492.55 â–ŧ 507.12 (-0.98%) NASDAQ 26,021.66 â–ŧ 354.69 (-1.34%) US Markets Closed â€ĸ 04:48 AM ET

BFRG

Bullfrog AI Holdings, Inc.

Price Chart
Latest Quote

$0.70

+0.00 (+0.59%)
Current Price
Previous Close $0.69
Open $0.67
Day High $0.75
Day Low $0.66
Volume 289,603
Fetched: 2026-06-18T08:48:06
Stock Information
Shares Outstanding 18.54M
Total Debt $134K
Cash Equivalents $5.08M
Revenue $117K
Net Income $-6.07M
Sector Healthcare
Industry Health Information Services
Market Cap $12.93M
EPS (TTM) $-0.54
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$7.91M
Sales$117K
Income$-6.07M
Book/sh$0.19
Cash/sh$0.27
Employees9
Financial Ratios
Quick Ratio7.79
Current Ratio8.15
Debt/Eq2.74
Returns & Margins
ROA-79.91%
ROE-149.35%
Gross Margin18.76%
Operating Margin-5273.54%
Ownership
Insider Ownership13.16%
Institutional Ownership2.87%
Insider & Institutional transactions data not available
Valuation Ratios
P/S110.85
P/B3.73
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.69
SMA50$0.75
SMA200$0.93
RSI47.76
ATR0.0722
Shares Float16.10M
Short Float3.47%
Short Ratio1.60
Rel Volume0.97
Performance History
Week+2.95%
Month+18.71%
Quarter+14.80%
6 Months-33.52%
YTD-20.68%
Year-59.89%
3 Years-82.37%
10 Years-89.26%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-17 $0.70 309,200
2026-06-16 $0.69 214,400
2026-06-15 $0.64 173,800
2026-06-12 $0.62 380,100
2026-06-11 $0.63 625,100
2026-06-10 $0.68 141,700
2026-06-09 $0.67 171,800
2026-06-08 $0.67 199,300
2026-06-05 $0.67 316,200
2026-06-04 $0.77 201,200
2026-06-03 $0.73 242,700
2026-06-02 $0.77 262,800
2026-06-01 $0.70 332,100
2026-05-29 $0.76 635,600
2026-05-28 $0.72 391,800
2026-05-27 $0.67 405,600
2026-05-26 $0.71 508,600
2026-05-22 $0.65 242,500
2026-05-21 $0.67 205,400
2026-05-20 $0.66 395,500
2026-05-19 $0.62 375,900
2026-05-18 $0.59 314,200
About Bullfrog AI Holdings, Inc.

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $94,778 $0 $5,200 $800
Cost Of Revenue $94,778 $0 $5,200 $800
Total Revenue $116,670 $0 $65,000 $10,000
Operating Revenue $116,670 $0 $65,000 $10,000
Expenses
Interest Expense $5,629 $18,158 $79,089 $347,145
Total Expenses $6,711,306 $7,236,383 $5,432,524 $2,465,801
Net Non Operating Interest Income Expense $96,568 $242,736 $104,614 $-346,686
Interest Expense Non Operating $5,629 $18,158 $79,089 $347,145
Operating Expense $6,616,528 $7,236,383 $5,427,324 $2,465,001
General And Administrative Expense $4,816,790 $5,013,118 $3,994,710 $1,855,731
Other Income Expense - - $-92,959 $459
Other Non Operating Income Expenses - - $-92,959 $459
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-6,498,068 $-6,993,647 $-5,355,869 $-2,802,487
Net Interest Income $96,568 $242,736 $104,614 $-346,686
Interest Income $102,197 $260,894 $183,703 $459
Normalized Income $-6,498,068 $-6,993,647 $-5,355,869 $-2,802,487
Net Income From Continuing And Discontinued Operation $-6,498,068 $-6,993,647 $-5,355,869 $-2,802,487
Total Operating Income As Reported $-6,594,636 $-7,236,383 $-5,367,524 $-2,455,801
Net Income Common Stockholders $-6,498,068 $-7,038,632 $-5,355,869 $-2,802,487
Net Income $-6,498,068 $-6,993,647 $-5,355,869 $-2,802,487
Net Income Including Noncontrolling Interests $-6,498,068 $-6,993,647 $-5,355,869 $-2,802,487
Net Income Continuous Operations $-6,498,068 $-6,993,647 $-5,355,869 $-2,802,487
Pretax Income $-6,498,068 $-6,993,647 $-5,355,869 $-2,802,487
Interest Income Non Operating $102,197 $260,894 $183,703 $459
Operating Income $-6,594,636 $-7,236,383 $-5,367,524 $-2,455,801
Gross Profit $21,892 $0 $59,800 $9,200
Special Income Charges - - $-92,959 $0
Per Share
Diluted EPS $-0.63 $-0.85 $-0.89 $-0.49
Basic EPS $-0.63 $-0.85 $-0.89 $-0.49
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-6,490,714 $-6,973,765 $-5,275,055 $-2,454,297
Reconciled Depreciation $1,725 $1,724 $1,725 $1,045
EBITDA (Bullshit earnings) $-6,490,714 $-6,973,765 $-5,275,055 $-2,454,297
EBIT $-6,492,439 $-6,975,489 $-5,276,780 $-2,455,342
Diluted Average Shares $10,337,073 $8,245,353 $6,049,819 $5,671,881
Basic Average Shares $10,337,073 $8,245,353 $6,049,819 $5,671,881
Diluted NI Availto Com Stockholders $-6,498,068 $-7,038,632 $-5,355,869 $-2,802,487
Research And Development $1,799,738 $2,223,265 $1,432,614 $609,270
Selling General And Administration $4,816,790 $5,013,118 $3,994,710 $1,855,731
Other Gand A $4,816,790 $5,013,118 $3,994,710 $1,855,731
Preferred Stock Dividends - $44,985 - -
Total Unusual Items - - $-92,959 $0
Total Unusual Items Excluding Goodwill - - $-92,959 $0
Other Special Charges - - $92,959 -
Salaries And Wages - - - $547,849
Fetched: 2026-06-13
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $2,136,329 $4,963,740 $2,592,236 $-3,057,352
Total Assets $2,808,351 $5,551,830 $2,776,586 $80,369
Total Non Current Assets $224,195 $4,250 $5,974 $7,699
Other Non Current Assets $105,000 - - -
Investmentin Financial Assets $116,670 $0 - -
Current Assets $2,584,156 $5,547,580 $2,770,612 $72,670
Prepaid Assets $400,451 $111,597 $145,882 $15,000
Cash Cash Equivalents And Short Term Investments $2,183,705 $5,435,983 $2,624,730 $57,670
Cash And Cash Equivalents $2,183,705 $5,435,983 $2,624,730 $57,670
Cash Financial - - - $57,670
Debt
Net Debt - - - $1,521,070
Total Debt - - - $1,578,740
Current Debt And Capital Lease Obligation - - - $1,578,740
Current Debt - - - $1,578,740
Other Current Borrowings - - - $1,578,740
Liabilities
Total Liabilities Net Minority Interest $672,022 $588,090 $184,350 $3,137,721
Total Non Current Liabilities Net Minority Interest $0 $0 $0 $0
Current Liabilities $672,022 $588,090 $184,350 $3,137,721
Payables And Accrued Expenses $672,022 $588,090 $184,350 $1,526,981
Payables $168,151 $435,934 $103,656 $543,993
Accounts Payable $168,151 $435,934 $103,656 $543,993
Current Deferred Liabilities - - $0 $32,000
Current Notes Payable - - - $0
Equity
Common Stock Equity $2,136,328 $4,963,739 $2,592,235 $-3,057,353
Preferred Stock Equity $1 $1 $1 $1
Total Equity Gross Minority Interest $2,136,329 $4,963,740 $2,592,236 $-3,057,352
Stockholders Equity $2,136,329 $4,963,740 $2,592,236 $-3,057,352
Retained Earnings $-23,291,624 $-16,793,556 $-9,754,924 $-4,399,055
Other
Ordinary Shares Number $11,418,183 $9,113,139 $6,094,644 $5,671,881
Share Issued $11,418,183 $9,113,139 $6,094,644 $5,671,881
Tangible Book Value $2,136,328 $4,963,739 $2,592,235 $-3,057,353
Invested Capital $2,136,328 $4,963,739 $2,592,235 $-1,478,613
Working Capital $1,912,134 $4,959,490 $2,586,262 $-3,065,051
Total Capitalization $2,136,329 $4,963,740 $2,592,236 $-3,057,352
Additional Paid In Capital $25,427,838 $21,757,204 $12,347,098 $1,341,662
Capital Stock $115 $92 $62 $41
Common Stock $114 $91 $61 $40
Preferred Stock $1 $1 $1 $1
Current Accrued Expenses $503,871 $152,156 $80,694 $982,988
Investments And Advances $116,670 $0 - -
Available For Sale Securities $116,670 - - -
Net PPE $2,525 $4,250 $5,974 $7,699
Accumulated Depreciation $-6,219 $-4,494 $-2,770 $-1,045
Gross PPE $8,744 $8,744 $8,744 $8,744
Other Properties $8,744 $8,744 $8,744 $8,744
Current Deferred Revenue - - $0 $32,000
Fetched: 2026-06-13
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-5,522,265 $-5,610,249 $-6,001,299 $-919,634
Operating Activities
Operating Cash Flow $-5,522,265 $-5,610,249 $-6,001,299 $-910,890
Cash Flow From Continuing Operating Activities $-5,522,265 $-5,610,249 $-6,001,299 $-910,890
Operating Gains Losses - - - -
Investing Activities
Investing Cash Flow $0 $0 $0 $-8,744
Cash Flow From Continuing Investing Activities - $0 $0 $-8,744
Capital Expenditure - - - $-8,744
Financing Activities
Issuance Of Capital Stock $2,467,533 $8,315,686 $7,293,651 $0
Financing Cash Flow $2,374,987 $8,421,502 $8,568,359 $967,290
Cash Flow From Continuing Financing Activities $2,374,987 $8,421,502 $8,568,359 $967,290
Net Other Financing Charges $-92,546 - - -
Net Common Stock Issuance $2,467,533 $8,315,686 $7,293,651 $0
Common Stock Issuance $2,467,533 $8,315,686 $7,293,651 $0
Other
Repayment Of Debt $-181,797 $-561,885 $-1,017,484 $-49,000
Issuance Of Debt $181,797 $561,885 $797,534 $1,016,290
Interest Paid Supplemental Data $5,629 $18,158 $93,916 $5,757
Income Tax Paid Supplemental Data $0 $0 $0 $0
End Cash Position $2,288,705 $5,435,983 $2,624,730 $57,670
Beginning Cash Position $5,435,983 $2,624,730 $57,670 $10,014
Changes In Cash $-3,147,278 $2,811,253 $2,567,060 $47,656
Proceeds From Stock Option Exercised $0 $105,816 $1,494,658 $0
Net Issuance Payments Of Debt $0 $0 $-219,950 $967,290
Net Short Term Debt Issuance $0 $0 $0 $967,290
Short Term Debt Payments $-181,797 $-561,885 $-697,534 $-49,000
Short Term Debt Issuance $181,797 $561,885 $697,534 $1,016,290
Change In Working Capital $80,117 $438,025 $-1,441,647 $1,136,922
Change In Payables And Accrued Expense $68,932 $403,740 $-1,278,765 $1,129,922
Change In Accrued Expense $336,715 $71,462 $-838,428 $654,523
Change In Payable $-267,783 $332,278 $-440,337 $475,399
Change In Account Payable $-267,783 $332,278 $-440,337 $475,399
Change In Prepaid Assets $11,185 $34,285 $-130,882 $-15,000
Other Non Cash Items $-116,670 - $162,959 $413,478
Stock Based Compensation $1,010,631 $943,649 $631,533 $340,152
Depreciation Amortization Depletion $1,725 $1,724 $1,725 $1,045
Depreciation And Amortization $1,725 $1,724 $1,725 $1,045
Depreciation $1,725 $1,724 $1,725 $1,045
Net Income From Continuing Operations $-6,498,068 $-6,993,647 $-5,355,869 $-2,802,487
Net Long Term Debt Issuance - $0 $-219,950 $0
Long Term Debt Payments - $0 $-319,950 $0
Long Term Debt Issuance - $0 $100,000 $0
Net PPE Purchase And Sale - $0 $0 $-8,744
Purchase Of PPE - $0 $0 $-8,744
Change In Other Working Capital - - $-32,000 $22,000
Fetched: 2026-06-13